Breaking News, Promotions & Moves

Bushu Pharmaceuticals Unveils Major Expansion Program

Japanese CDMO will invest $100 million to expand capacity and portfolio, Koichiro Matsumoto named president and CEO.

By: Contract Pharma

Contract Pharma Staff

Bushu Pharmaceuticals Ltd., one of Japan’s largest contract manufacturers of pharmaceutical products, has unveiled a major capital program costing $100 million to expand its footprint, capacity and portfolio of services over the next five years.   Bushu is nearing completion of its 42,000 square foot cold chain warehouse facility at its Misato plant north of Tokyo. The new facility will be commissioned and validated by September of this year for storage of temperature-controlled sterile dr...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters